DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel about Leading AbbVie Inc. Class Action Lawsuit Pharmaceutical Investing
DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 6, 2022 in AbbVie Lawsuit - ABBV Pharmaceutical Investing
ABBVIE INC. SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against AbbVie Inc. Pharmaceutical Investing
Premier Health Enters Into Binding Agreement to Acquire Leading Ontario Agency Canadian Health Care Agency Medical Device Investing
Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference Pharmaceutical Investing
CLASS ACTION UPDATE for RIVN, CELH and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies AbbVie, Inc. Investors of Class Action and Encourages Investors to Contact the Firm Pharmaceutical Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
